Sofinnova Investments’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-4,280,308
| Closed | -$17.1M | – | 67 |
|
|
2025
Q2 | $17.1M | Hold |
4,280,308
| – | – | 1.16% | 28 |
|
|
2025
Q1 | $3.9M | Hold |
4,280,308
| – | – | 0.29% | 53 |
|
|
2024
Q4 | $11.9M | Hold |
4,280,308
| – | – | 0.87% | 29 |
|
|
2024
Q3 | $22.4M | Hold |
4,280,308
| – | – | 1.85% | 18 |
|
|
2024
Q2 | $19.1M | Hold |
4,280,308
| – | – | 1.2% | 33 |
|
|
2024
Q1 | $32.8M | Hold |
4,280,308
| – | – | 1.93% | 21 |
|
|
2023
Q4 | $18.2M | Hold |
4,280,308
| – | – | 1.02% | 26 |
|
|
2023
Q3 | $18M | Buy |
4,280,308
+625,000
| +17% | +$3.18M | 1.25% | 25 |
|
|
2023
Q2 | $20.4M | Hold |
3,655,308
| – | – | 1.34% | 20 |
|
|
2023
Q1 | $20.9M | Hold |
3,655,308
| – | – | 1.42% | 23 |
|
|
2022
Q4 | $3.84M | Hold |
3,655,308
| – | – | 0.23% | 40 |
|
|
2022
Q3 | $9.8M | Hold |
3,655,308
| – | – | 0.62% | 32 |
|
|
2022
Q2 | $17.4M | Buy |
3,655,308
+1,627,000
| +80% | +$7.08M | 1.55% | 18 |
|
|
2022
Q1 | $8.3M | Hold |
2,028,308
| – | – | 0.7% | 34 |
|
|
2021
Q4 | $13.8M | Hold |
2,028,308
| – | – | 0.89% | 31 |
|
|
2021
Q3 | $23.5M | Hold |
2,028,308
| – | – | 1.51% | 16 |
|
|
2021
Q2 | $34.6M | Hold |
2,028,308
| – | – | 2.1% | 12 |
|
|
2021
Q1 | $40.2M | Hold |
2,028,308
| – | – | 2.53% | 10 |
|
|
2020
Q4 | $41.9M | Hold |
2,028,308
| – | – | 2.6% | 8 |
|
|
2020
Q3 | $53.3M | Buy |
+2,028,308
| New | +$50.4M | 4.18% | 5 |
|